'Fast Money' Recap: Dec. 30

However, he doubts that will happen because he believes the U.S., as the pre-eminent political, economic and military power in the world, will preserve its reserve currency status. Sixty percent the world's reserve assets are currently parked in US dollars, he said.

He said money will still come to the US because it has a mature financial and regulatory system.

Lee shifted the discussion to the recent rally in healthcare stocks and what that bodes for 2009. Commenting on the uptick the last couple of days in Pfizer (PFE) and Merck (MRK) shares, Najarian said a lot of investors who have been chasing the dividend of those stocks should be careful.

"We're looking for growth here and neither of them has put much out there to impress the Street," he said.

Najarian said Merck at least has signaled a jump into the pharmaceutical area, which he regards as "positive." He said he liked biotech names such as Celgene(CELG), Gilead Sciences (GILD) and Teva Pharma(TEVA).

Continuing her look at the outlook for 2010 on the assumption that 2009 will be miserable, Lee asked the panel for some trades they would make.

Najarian offered these names: First Solar(FSLR), Energy Conversion Devices(ENER) and Eastman Chemicals(EMN).

Tatro liked Claymore/Mac Global Solar Energy(TAN) and Fuel System Solutions(FSYS).

In the final trades of the day, Tatro liked UltraShort Utilities ProShares(SDP) and Najarian said he liked Charles Schwab (SCHW).

"Check out "'Fast Money' Portfolios of the Week" on Stockpickr every Thursday.

>To order reprints of this article, click here: Reprints